The oncological characteristics of non-prostate-specific membrane antigen (PSMA)-expressing primary prostate cancer on preoperative PSMA positron emission tomography/computed tomography
- PMID: 36117468
- PMCID: PMC9828411
- DOI: 10.1111/bju.15896
The oncological characteristics of non-prostate-specific membrane antigen (PSMA)-expressing primary prostate cancer on preoperative PSMA positron emission tomography/computed tomography
Keywords: #PCSM; #ProstateCancer; #uroonc; PSMA negative; biochemical recurrence; oncological outcomes; positron emission tomography/computed tomography; prostate cancer; prostate-specific membrane antigen; robot-assisted radical prostatectomy.
Figures
References
-
- Crocerossa F, Marchioni M, Novara G et al. Detection rate of prostate specific membrane antigen tracers for positron emission tomography/Computerized tomography in prostate cancer biochemical recurrence: a systematic review and network meta‐analysis. J Urol 2021; 205: 356–69 - PubMed
-
- Eiber M, Herrmann K, Calais J et al. Prostate cancer molecular imaging standardized evaluation (PROMISE): proposed miTNM classification for the interpretation of PSMA‐ligand PET/CT. J Nucl Med 2018; 59: 469–78 - PubMed
-
- Bronsert P, Reichel K, Ruf J. Loss of PSMA expression in non‐neuroendocrine dedifferentiated acinar prostate cancer. Clin Nucl Med 2018; 43: 526–8 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous